Christopher E. Brightling
Impact in
- Physiology top 0.01%
- Asthma and respiratory diseases
- Pulmonary and Respiratory Medicine top 0.02%
- Respiratory and Cough-Related Research
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Inhalation and Respiratory Drug Delivery
Papers in
- Physiology 285
- Asthma and respiratory diseases 281
-
- Chronic Obstructive Pulmonary Disease (COPD) Research 111
- Respiratory and Cough-Related Research 88
- Inhalation and Respiratory Drug Delivery 33
- Co-authors
- Ian Pavord (129 shared papers)Andrew J. Wardlaw (94 shared papers)Peter Bradding (80 shared papers)Ruth H. Green (16 shared papers)Beverley Hargadon (27 shared papers)Debbie Parker (14 shared papers)Dominick Shaw (14 shared papers)Pranabashis Haldar (19 shared papers)
- Journals
- Thorax (40 papers)Journal of Allergy and Clinical Immunology (29 papers)European Respiratory Journal (29 papers)American Journal of Respiratory and Critical Care Medicine (24 papers)CHEST Journal (22 papers)
- Partner nations
- United KingdomUnited StatesGermany
In The Last Decade
Christopher E. Brightling
476 papers receiving 29.6k citations
Christopher E. Brightling's Hit Papers
Peers
Comparison fields: 5 of 180
- Physiology 18.0k
- Pulmonary and Respiratory Medicine 13.2k
- Immunology and Allergy 2.5k
- Emergency Medical Services 2.5k
- Immunology 5.7k
Countries citing papers authored by Christopher E. Brightling
This map shows the geographic impact of Christopher E. Brightling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher E. Brightling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher E. Brightling more than expected).
Fields of papers citing papers by Christopher E. Brightling
This network shows the impact of papers produced by Christopher E. Brightling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher E. Brightling. The network helps show where Christopher E. Brightling may publish in the future.
Co-authors
The 25 scholars most cited alongside Christopher E. Brightling, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 506 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Cluster Analysis and Clinical Asthma Phenotypes Hit paper breakdown → | 2008 | 1479 |
| 2 | Mepolizumab and Exacerbations of Refractory Eosinophilic Asthma Hit paper breakdown → | 2009 | 1442 |
| 3 | Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial Hit paper breakdown → | 2002 | 1339 |
| 4 | Asthma Hit paper breakdown → | 2017 | 1267 |
| 5 | Mast-Cell Infiltration of Airway Smooth Muscle in Asthma Hit paper breakdown → | 2002 | 972 |
| 6 | Evidence of a Role of Tumor Necrosis Factor α in Refractory Asthma Hit paper breakdown → | 2006 | 670 |
| 7 | Tezepelumab in Adults and Adolescents with Severe, Uncontrolled Asthma Hit paper breakdown → | 2021 | 667 |
| 8 | Blood Eosinophils to Direct Corticosteroid Treatment of Exacerbations of Chronic Obstructive Pulmonary Disease: A Randomized Placebo-Controlled Trial Hit paper breakdown → | 2012 | 442 |
| 9 | 2000 | 440 | |
| 10 | Severe eosinophilic asthma treated with mepolizumab stratified by baseline eosinophil thresholds: a secondary analysis of the DREAM and MENSA studies Hit paper breakdown → | 2016 | 417 |
| 11 | 2007 | 357 | |
| 12 | 2007 | 355 | |
| 13 | 1999 | 331 | |
| 14 | 2010 | 322 | |
| 15 | 2007 | 310 | |
| 16 | 2012 | 308 | |
| 17 | 2015 | 300 | |
| 18 | Lung microbiome dynamics in COPD exacerbations Hit paper breakdown → | 2016 | 297 |
| 19 | 2001 | 284 | |
| 20 | 2005 | 277 |
About Christopher E. Brightling
Christopher E. Brightling is a scholar working on Physiology, Pulmonary and Respiratory Medicine, Immunology, Emergency Medical Services and Surgery, having authored 506 papers that have together received 30.6k indexed citations. Recurring topics across this work include Asthma and respiratory diseases (281 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (111 papers), Respiratory and Cough-Related Research (88 papers), Pediatric health and respiratory diseases (43 papers), Inhalation and Respiratory Drug Delivery (33 papers), IL-33, ST2, and ILC Pathways (29 papers), Eosinophilic Esophagitis (22 papers) and Allergic Rhinitis and Sensitization (19 papers). The work is most often cited by research in Physiology (18.0k citations), Pulmonary and Respiratory Medicine (13.2k citations), Immunology and Allergy (2.5k citations), Emergency Medical Services (2.5k citations) and Immunology (5.7k citations). Christopher E. Brightling has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Ian Pavord, Andrew J. Wardlaw, Peter Bradding, Ruth H. Green, Beverley Hargadon, Debbie Parker, Dominick Shaw, Pranabashis Haldar, Salman Siddiqui and Helen K. Reddel. Their work appears in journals such as Thorax, Journal of Allergy and Clinical Immunology, European Respiratory Journal, American Journal of Respiratory and Critical Care Medicine and CHEST Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.